NUCB2, a gene involved in regulating appetite and energy balance, may indirectly affect the efficacy or safety of the diuretic drug hydrochlorothiazide, which is used to treat hypertension. This potential pharmacodynamic interaction occurs because genetic variations in NUCB2 could influence Nesfatin-1 levels, thereby altering body water and salt retention, which can affect how hydrochlorothiazide controls blood pressure.